GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients

MLA

Anna Rydén, et al. “GAD-Alum Treatment Induces GAD65-Specific CD4+CD25highFOXP3+ Cells in Type 1 Diabetic Patients.” Clinical Immunology, vol. 138, Jan. 2011, pp. 117–26. EBSCOhost, https://doi.org/10.1016/j.clim.2010.10.004.

APA

Anna Rydén, Stina Axelsson, Maria Hjorth, Maria Faresjö, Johnny Ludvigsson, & Rosaura Casas. (2011). GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients. Clinical Immunology, 138, 117–126. https://doi.org/10.1016/j.clim.2010.10.004

Chicago

Anna Rydén, Stina Axelsson, Maria Hjorth, Maria Faresjö, Johnny Ludvigsson, and Rosaura Casas. 2011. “GAD-Alum Treatment Induces GAD65-Specific CD4+CD25highFOXP3+ Cells in Type 1 Diabetic Patients.” Clinical Immunology 138 (January): 117–26. doi:10.1016/j.clim.2010.10.004.